Sarcoma Clinical Trials
Sarcoma clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for sarcoma. Corterve aggregates actively recruiting Sarcoma studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Sarcoma studies
- IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsNCT05039801PHASE1M.D. Anderson Cancer CenterAdvanced Endometrial CarcinomaHouston, Texas
- PEEL-224, Vincristine and Temozolomide in Pediatric Solid TumorsNCT06721689PHASE1, PHASE2Theodore LaetschRefractory Solid TumorsLos Angeles, California
- Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic AnalysisNCT04557969National Cancer Institute (NCI)Gastric CancerBethesda, Maryland
- Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid TumorsNCT02013336PHASE1South Plains Oncology ConsortiumRecurrent or Refractory Solid TumorsCincinnati, Ohio
- Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive OsteosarcomaNCT05588648PHASE1, PHASE2MedPacto, Inc.OsteosarcomaCleveland, Ohio
- Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS StudyNCT05019703PHASE2M.D. Anderson Cancer CenterLocally Advanced OsteosarcomaBoston, Massachusetts
- Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and CancerNCT00006518National Cancer Institute (NCI)HIVBethesda, Maryland
- Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal SarcomaNCT04031677PHASE3European Organisation for Research and Treatment of Cancer - EORTCRetroperitoneal SarcomaBirmingham, Alabama
- Eflornithine (DFMO) for Ewing Sarcoma and OsteosarcomaNCT07321912PHASE2Milton S. Hershey Medical CenterOsteosarcomaTampa, Florida
- Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated SarcomasNCT06422806PHASE3National Cancer Institute (NCI)Metastatic Dedifferentiated LiposarcomaPhoenix, Arizona
- Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR TrialNCT07188532NAMayo ClinicEwing SarcomaPhoenix, Arizona
- Lead-212 PSV359 Therapy for Patients With Solid TumorsNCT06710756PHASE1, PHASE2Perspective TherapeuticsPancreatic Ductal AdenocarcinomaLos Angeles, California
Sarcoma trials by state
Sarcoma trials by metro
Frequently asked questions
- How do I find recruiting Sarcoma clinical trials?
- Browse the actively recruiting Sarcoma studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Sarcoma clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Sarcoma clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.